PAMORELIN Trademark

Trademark Overview


On Tuesday, August 15, 2017, a trademark application was filed for PAMORELIN with the United States Patent and Trademark Office. The USPTO has given the PAMORELIN trademark a serial number of 87568745. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 23, 2025. This trademark is owned by Debiopharm International SA. The PAMORELIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, chemiotherapeutical medicines and medicines that act on the endocrinal functions, hormones, and on metabolism for the treatment of prostate cancer, endometriosis, precocious puberty, breast cancer, in vitro fertilization, ovarian cancer, fibroma and polycystic ovarian cancer

General Information


Serial Number87568745
Word MarkPAMORELIN
Filing DateTuesday, August 15, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 23, 2025
Registration Number5604338
Registration DateTuesday, November 13, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 28, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, chemiotherapeutical medicines and medicines that act on the endocrinal functions, hormones, and on metabolism for the treatment of prostate cancer, endometriosis, precocious puberty, breast cancer, in vitro fertilization, ovarian cancer, fibroma and polycystic ovarian cancer
Translation of Words in MarkThe wording "PAMORELIN" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 23, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDebiopharm International SA
Party Type30 - Original Registrant
Legal Entity Type33 - NOT AVAILABLE
AddressLausanne CH-1002
CH

Party NameDebiopharm International SA
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressLausanne CH-1002
CH

Party NameDebiopharm International SA
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressLausanne CH-1002
CH

Trademark Events


Event DateEvent Description
Friday, November 17, 2017ASSIGNED TO EXAMINER
Friday, August 18, 2017NEW APPLICATION ENTERED
Monday, August 21, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 24, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 8, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 28, 2018PUBLISHED FOR OPPOSITION
Tuesday, August 28, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 13, 2018REGISTERED-PRINCIPAL REGISTER
Monday, November 13, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, May 23, 2025CANCELLED SEC. 8 (6-YR)
Wednesday, May 30, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 20, 2017NON-FINAL ACTION WRITTEN
Monday, November 20, 2017NON-FINAL ACTION E-MAILED
Monday, November 20, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 21, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 29, 2018ASSIGNED TO LIE
Wednesday, May 30, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE